Core Scientific, Inc./tx
For the period ended Mar 31, 2026. Filed May 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 6, 2026
CORZ$13.13+3.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
(in thousands)
| Three Months Ended March 31, | ||
|---|---|---|
| 2026 | 2025 | |
| Cash flows from Operating Activities: | ||
| Net (loss) income | $(347,188) | $576,251 |
| Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities: | ||
| Depreciation and amortization | 16,648 | 19,731 |
| Loss on disposal of property, plant and equipment | 13,638 | 6 |
| Impairment of property, plant and equipment | 266,488 | — |
| Change in right-of-use assets | 3,169 | 2,676 |
| Stock-based compensation | 17,761 | 16,185 |
| Digital asset self-mining | (30,119) | (67,441) |
| Proceeds from sales of digital assets generated by self-mining revenues1 | 208,249 | — |
| Decrease in fair value of digital assets | 6,558 | 10,688 |
| Change in fair value of warrant liabilities | 31,835 | (634,280) |
| Change in fair value of contingent value rights | (1,036) | 12,816 |
| Amortization of debt discount | 1,675 | 1,732 |
| Changes in operating assets and liabilities: | ||
| Customer funding receivable and other current assets | 10,107 | (10,463) |
| Accounts payable | 5,874 | (14,295) |
| Accrued expenses | (16,361) | 2,712 |
| Deferred revenue from colocation services | 98,832 | 42,005 |
| Deferred revenue from hosted mining services | (456) | 734 |
| Other noncurrent assets and liabilities, net | (35,797) | (4,098) |
| Net cash provided by (used in) operating activities | 249,877 | (45,041) |
| Cash flows from Investing Activities: | ||
| Purchases of property, plant and equipment | (389,226) | (83,980) |
| Proceeds from sales of property and equipment | 2,629 | — |
| Purchase of equity investments | — | (5,000) |
| Investments in intangible assets | (55) | (36) |
| Net cash used in investing activities | (386,652) | (89,016) |
| Cash flows from Financing Activities: | ||
| Principal repayments of finance leases | (1,095) | (509) |
| Principal payments on debt | — | (3,955) |
| Taxes paid related to net share settlement of equity awards | (21,722) | — |
| Proceeds from exercise of warrants | 81 | 266 |
| Proceeds from the issuance of term loan facility, net | 995,000 | — |
| Issuance costs for term loan facility | (882) | — |
| Net cash provided by (used in) financing activities | 971,382 | (4,198) |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 834,607 | (138,255) |
| Cash, cash equivalents and restricted cash—beginning of period | 311,378 | 836,980 |
| Cash, cash equivalents and restricted cash—end of period | $1,145,985 | $698,725 |
Certain prior year amounts have been reclassified for consistency with the current year presentation.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.